Mylan NV (NASDAQ:MYL) stock has been a media darling for some time, and for all the wrong reasons. The price of the “EpiPen” skyrocketed in recent months and this news only served to increase the scrutiny received by this sector, as …
Mylan's EpiPen price hikes made it the face of corporate greed last summer. Now, the drug maker is lavishing a top exec with an eye-popping pay package. Despite the EpiPen scandal and a slumping stock price, Mylan (MYL) rewarded …
Value investing is easily one of the most popular ways to find great stocks in any market environment. After all, who wouldn't want to find stocks that are either flying under the radar and are compelling buys, or offer up tantalizing …
NASDAQ4mon
Mylan was off to what seemed like it was going to be a rough day in the market today. At the opening bell, the stock was trading slightly in the green. From there, it quickly turned red as it took a mad-dash for the bottom. However, minutes …
Mylan (MYL) stock dipped to a six-week low Thursday after indicating late Wednesday the Food and Drug Administration is looking for more information into its generic version of Teva Pharmaceuticals' (TEVA) Copaxone. In midday trading on …
oversees New York City pensions that together own more than 1.1 million shares of Mylan stock. “From the EpiPen pricing debacle to embracing complex tax avoidance strategies, Mylan’s board appears more focused on financial engineering …
The original version of this article can be accessed at https://www.chaffeybreeze.com/2017/07/14/tiaa-cref-investment-management-llc-raises-stake-in-mylan-n-v-nasdaqmyl-updated.html. In related news, President Rajiv Malik sold 25,000 …
Camber Capital Management Llc acquired 272,889 shares as Mylan Nv (MYL)'s stock declined 9.77%. Conning Inc. increased its stake in Mylan N.V.by 1.3% in the first quarter. LLC now owns 3,015 shares of the company's stock
Mylan NV MYL, -0.81% shares rose 2.8% in premarket trade Tuesday after the company reported a first-quarter profit beat and revenue miss. Earnings for the latest quarter rose to $66.4 million, or 12 cents per share, from $13.9 million, or 3 …